Further studies currently in progress are working to evaluate the anti-GBM performance of 9X particles, specifically looking at their effects on crucial regulator molecules (microRNA-21) and essential cellular proteins (PTEN, STAT3, PDCD4) affecting overall GBM proliferation, invasiveness, and survivability. The gene discussed is STAT3; the disease is glioblastoma.